Actionable news
0
All posts from Actionable news
Actionable news in GNCA: GENOCEA BIOSCIENCES Inc,

UPDATE 1-Genocea stops pneumonia vaccine development after study fails

(Adds details, share movement)

Oct 19 (Reuters) - Drug developer Genocea Biosciences Inc said it was suspending the development of a vaccine for pneumonia-causing bacteria after it failed to significantly reduce infection in a mid-stage study.

The company's shares fell 34 percent to $4.75 in premarket trading.

Genocea said it was dropping the development of the vaccine, GEN-004, from...


More